9.1 Million People Living with Chronic Diseases – An Alarming Reality of the UK Healthcare System
In the context of the UK’s rapidly aging population, the figure of 9.1 million people in England projected to live with major illnesses by 2040 – a significant increase of 2.5 million people compared to 2019 – is becoming an urgent warning for the national health system. According to the “Health in 2040: Projected Patterns of Illness in England” report published by the Health Foundation in 2023, this rate is equivalent to one in five adults in England facing long-term health conditions such as type 2 diabetes, cardiovascular disease, cancer, heart failure, chronic pain, and anxiety-depression. These numbers not only reflect a massive economic burden on the NHS (National Health Service), but also portray a realistic picture of the daily lives of millions of individuals: mornings waking up with persistent joint pain, sleepless nights worrying about cardiovascular complications, or the constant fatigue from uncontrolled blood sugar.
Imagine Mr. David, a 68-year-old retired engineer living in Birmingham. In 2018, he was diagnosed with type 2 diabetes accompanied by hypertension – the two most common chronic diseases in the UK, affecting more than 4.9 million people according to the NHS Diabetes Prevalence Model 2024. Initially, he just thought it was the result of a busy lifestyle: shift work, poor diet, and lack of exercise. But after only two years, his condition deteriorated rapidly. His HbA1c (hemoglobin A1c, an index measuring average blood sugar control over 2-3 months) fluctuated at 8.5%, higher than the ideal threshold of below 7% according to NICE (National Institute for Health and Care Excellence) guidelines. He began to experience complications: numbness in the feet due to peripheral neuropathy, prolonged fatigue, and an increased risk of kidney failure. Every month, he had to wait in long lines at the GP (General Practitioner) clinic to get prescriptions for metformin and statins, but appointments were often delayed due to system overload – a common problem in the UK with an average wait time of 14 weeks for specialist consultations. Mr. David’s emotions at that time were a mix of helplessness and anger: “I feel like I’m fighting alone, with dull pains reminding me that the disease is controlling my life.” According to the Health Survey for England 2024, 46% of adults aged 16 and over are living with at least one chronic disease, and cases like Mr. David’s are not rare. These numbers emphasize the urgent need for more effective chronic disease management UK, where building a Personal Care Team (PCT) can change the outcome, helping patients like him regain control over their health. And this is when technological solutions like StrongBody AI’s Smart Matching AI step in, bringing hope to millions by connecting them with a global team of experts instantly and personally.
This increase is not just dry statistics; it reflects emotional personal stories. Ms. Emily, 45 years old in London, a primary school teacher, discovered she had chronic pain after a back injury in 2020. According to the Faculty of Pain Medicine 2024 report, 43% of UK adults – nearly 28 million people – are living with chronic pain that affects daily activities. For Emily, pain radiating from the lumbosacral region made it difficult for her to stand and teach, leading to mild depression and a 30% reduction in work performance. She tried basic physical therapy at the NHS, but the lack of coordination among experts made the process slow. “I cry every night thinking that my life will always be like this,” Emily shared in an interview with The Guardian in 2024. Such stories emphasize that chronic disease management UK is not only a medical issue but also a mental and social battle, requiring a more comprehensive approach than ever before.
What is Chronic Disease Management? – Long-term Monitoring and Core Strategies in the UK Context
Chronic disease management is a comprehensive, continuous process aimed at controlling, minimizing symptoms, and preventing complications of health conditions lasting at least three months, often a lifetime. Unlike emergency treatment, chronic disease management focuses on long-term monitoring, patient education, and lifestyle adjustments to improve quality of life. In the UK, according to the guidelines of NICE and the NHS Long Term Plan 2019 (updated 2024), this management includes core elements: periodic monitoring of biological markers (such as systolic blood pressure below 130/80 mmHg for cardiovascular patients), pharmacological adherence (for example, using SGLT2 inhibitors for diabetes to reduce the risk of heart failure by 30-40%), non-pharmacological interventions (low-carb nutrition for blood sugar control), and psychological support to reduce the risk of depression – a common complication in 20-30% of chronic patients according to a British Medical Journal 2023 study.
In the UK health system, chronic disease management mainly takes place at the primary care level through the GP-led primary care model, where patients are classified according to QOF (Quality and Outcomes Framework) to monitor indicators such as BMI below 30 for obese patients with diabetes. However, with the increase in multimorbidity (multiple diseases simultaneously) – affecting 14.8% of the English population according to ONS 2024 data – long-term monitoring requires multidisciplinary coordination to avoid fragmented care. For example, in patients with COPD (chronic obstructive pulmonary disease), management includes monitoring FEV1 (forced expiratory volume in 1 second) via annual spirometry, combined with pulmonary rehabilitation programs to improve exercise tolerance by 20-30%, and using bronchodilators such as long-acting beta-agonists to reduce emergency frequency.
To illustrate this complexity, let’s go back to Mr. David in Birmingham. After diagnosis, he participated in the NHS DESMOND (Diabetes Education and Self Management for Ongoing and Newly Diagnosed) program – a group education model that helps patients understand the mechanism of insulin resistance and the role of glucagon-like peptide-1 agonists in blood sugar control. But his long-term monitoring met obstacles: GP examination schedule only twice/year, while he needed monthly monitoring to adjust drug dosage based on eGFR (estimated glomerular filtration rate) index for kidney function. As a result, he experienced a serious urinary tract infection in 2021, leading to a three-day hospitalization and a cost of £2,500 for the NHS. His emotion at that time was regret: “I knew I needed more support, but the system was so overloaded that it made me feel abandoned.” Research from Nuffield Trust 2025 shows that more than 15 million UK people (more than 25% of the population) have long-term conditions, and the lack of personalized monitoring leads to 20% of unnecessary re-hospitalization cases.
Another story is Mr. Tom, 52 years old in Manchester, living with chronic cardiovascular disease after a myocardial infarction in 2019. His management includes monitoring lipid profile (LDL cholesterol below 1.8 mmol/L according to NICE guidelines) and a cardiac rehabilitation program with aerobic exercises 150 minutes/week. However, with a night shift work schedule, he often misses follow-up sessions, leading to uncontrolled blood pressure and a 15% increased risk of recurrence. “I love my job, but the disease makes me worry for my family – my wife has to take care of me like a child,” Tom confided. These examples emphasize that chronic disease management UK needs to go beyond the traditional model, towards personalized long-term monitoring, where technology such as health monitoring applications (for example, NHS App) combined with a support team can reduce drug non-compliance rate from 50% to below 30%, according to data from The King’s Fund 2024.
Deepening professional knowledge, chronic disease management often uses the WHO ICF (International Classification of Functioning, Disability and Health) model, analyzed in three dimensions: body functions, activities, and participation. In the UK, this is applied through Person-Centred Care Plans, where patients like Mr. David can set SMART (Specific, Measurable, Achievable, Relevant, Time-bound) goals such as reducing HbA1c by 1% in six months through the DASH (Dietary Approaches to Stop Hypertension) diet. However, the big challenge is regional inequality: in rural areas like Cornwall, the waiting time for specialist consultation is up to 20 weeks, compared to 10 weeks in London, according to the NHS England 2024 report. Therefore, the demand for digital platforms supporting remote monitoring (telemanagement) is increasingly urgent, helping patients manage chronic disease management UK more effectively without being entirely dependent on physical appointments.
Aging Population and Factors Driving Chronic Diseases in the UK
The aging population is the main driver behind the explosion of chronic diseases in the UK, with the proportion of people over 65 reaching 18% of the population (more than 10 million people) according to the “The State of Ageing 2023-24” report by the Centre for Ageing Better. Forecasts from the ONS (Office for National Statistics) show that by 2040, this age group will increase to 24%, equivalent to an additional 3.5 million seniors. Aging not only extends life expectancy but also increases the risk of multimorbidity, where diseases such as osteoarthritis combined with cardiovascular disease increase the burden by 68% in the over-80 group, according to a UCL 2024 study. Related factors include decreased immune function (immunosenescence), accumulation of oxidative stress, and hormonal changes, leading to a 49% increase in diabetes and a 92% increase in heart failure by 2040, according to the Health Foundation.
Although lifestyle (smoking, poor diet) contributes, research from News-Medical.net in 2025 points out that aging accounts for 70% of the increase, even if risk factors improve. For example, the obesity rate (BMI >30) in the 65+ group is 30%, 20% higher than in the younger group, due to decreased metabolism and less activity. In the UK, the baby boomers generation (born 1946-1964) is entering senior age with worse health than the previous generation, according to a UCL report in October 2024: cancer diagnoses increased, heart problems and high cholesterol are higher despite extended life expectancy.
Let’s look at the case of Mrs. Margaret, 72 years old in Edinburgh, Scotland. She belongs to the baby boomer generation, used to be a nurse and maintained a healthy lifestyle with a Mediterranean diet and daily walking. But in 2022, she was diagnosed with rheumatoid arthritis accompanied by osteoporosis, two common diseases in postmenopausal women due to decreased estrogen leading to increased inflammatory cytokines (such as TNF-alpha). Her DAS28 (Disease Activity Score 28) index was at 5.1, indicating medium-high disease activity, causing knee and hip joint pain that made it difficult for her to take care of her grandchildren. “I used to run and jump everywhere, now every step is a challenge. I fear I will become a burden to my children,” Mrs. Margaret shared with a feeling of sadness mixed with determination. The diagnostic process took six months due to waiting for a DEXA scan (dual-energy X-ray absorptiometry) for bone density, and initial treatment with methotrexate only reduced symptoms by 20%. Aging has exacerbated the condition: bone density decreases 1-2% per year after age 50 in women, according to NICE guidelines. She started a monitoring program at the local clinic, but lacked a nutritionist to supplement vitamin D and calcium, leading to a 50% increased risk of fracture.
Another example is Mr. Raj, 60 years old of Indian origin in Leicester, who immigrated to the UK in 1990. As a taxi driver, he developed metabolic syndrome – including central obesity, increased triglycerides, and insulin resistance – due to a high-carb diet from family culture combined with little sleep. Aging increases the risk: the rate of metabolic syndrome in UK South Asian men is twice the average, according to the British Heart Foundation 2024. His HOMA-IR (Homeostatic Model Assessment for Insulin Resistance) index was 4.2, higher than the 2.5 threshold, leading to pre-diabetes. “I work 12 hours/day to support my family, but now my body betrays me with fatigue and blurred vision,” Mr. Raj told with anxiety about the future. He tried to change by reducing salt and increasing vegetables, but the lack of personalized guidance made the process slow, and in 2023 he was hospitalized for chest pain due to 70% coronary artery stenosis.
These stories illustrate that aging is not just the number of years but the accumulation of biological risks, requiring chronic disease management UK to integrate early screening such as the FRAX tool for fracture risk or the Framingham Risk Score for cardiovascular disease. The UK government’s “Future of an Ageing Population” report 2017 (updated 2024) emphasizes the need to invest in prevention, but with an aging population, solutions such as remote monitoring will be the key to reducing the burden.
Operating Mechanism: Multidisciplinary Coordination Team in Chronic Disease Management UK
The operating mechanism of the Personal Care Team (PCT) in chronic disease management is based on multidisciplinary coordination, where experts from internal medicine, nutrition, physical therapy, and psychology work in sync to create a comprehensive care plan. According to the NHS MDT (Multidisciplinary Team) model, this mechanism includes an initial assessment using tools such as the WHO Disability Assessment Schedule (WHODAS) to measure function, followed by personalized planning with short-term goals (for example, reducing BMI by 5% in three months through the Weight Management Programme) and periodic monitoring via quarterly MDT meetings. Benefits include reducing fragmented care by sharing EPR (Electronic Patient Records), improving treatment compliance by 25% according to The Lancet 2025 study.
In the UK, MDT is deployed through Integrated Care Systems (ICS), where GPs coordinate with secondary care to manage multimorbidity. For example, in a patient with heart failure NYHA class II (New York Heart Association), the MDT includes a cardiologist monitoring ejection fraction via echocardiography, a nurse practitioner guiding a low-sodium diet (<2g/day), and a psychologist supporting CBT (Cognitive Behavioral Therapy) to reduce anxiety – a factor that increases hospital admission risk by 40%.
StrongBody AI lồng ghép perfectly into this mechanism through the Build Personal Care Team feature, where users select fields of interest (such as GROUP 4: LONGEVITY & HEALTH with Longevity Coach and Health Optimization Coach) and the Smart Matching AI system automatically pairs them with global experts. For Mr. David, after registering at https://strongbody.ai, he selected interests in diabetes and cardiovascular. The system, based on AI analyzing the profile (including HbA1c index and history), suggested a PCT consisting of an endocrinologist from England (General Internal Medicine Doctor), a sports nutritionist from India (Sports Nutritionist), and a lifestyle habit coach from the USA (Lifestyle Habit Coach). The process started with an automated greeting via MultiMe Chat: the endocrinologist sent a voice message translated into English, explaining the monthly HbA1c monitoring plan with a target below 7%. Mr. David sent a private request about diet, received an offer from the nutritionist: a low-GI (glycemic index) plan with 1,800 calories/day, including a formula for calculating carbs (45-60g/meal). He accepted the offer via Stripe, paid £50, and monitored progress via chat with meal images. After two months, HbA1c decreased to 7.2%, blood pressure stabilized at 128/78 mmHg, and he felt “as if empowered back” – a natural, safe process thanks to the platform’s escrow.
Another story is Mrs. Margaret with arthritis. Her PCT included a rheumatologist monitoring DAS28, an occupational therapist guiding adaptive tools (such as ergonomic gripping tools), and a mindfulness coach reducing inflammatory stress. Coordination mechanism via shared goals: reducing flare-ups by 50% by combining DMARDs (disease-modifying antirheumatic drugs) such as leflunomide and weekly yoga.
Forecasted Increase of 2.5 Million People with Chronic Diseases by 2040 in the UK and Detailed Trend Analysis
Forecasts from “Health in 2040: projected patterns of illness in England” by The Health Foundation (published in 2023, with updates based on the latest ONS population data) show that the number of people living with major illness (serious diseases, including chronic diseases with a major impact on quality of life and use of health services) in England will increase by 37%, reaching 9.1 million people by 2040 – an increase of 2.5 million cases compared to 2019. This figure is equivalent to nearly 1/5 of the adult population (from 1/6 to nearly 1/5), with most of the increase coming from the aging population, especially the over-70 group. The report emphasizes that 80% of this increase is due to the rising number of elderly people, not because disease rates are sharply increasing in younger age groups.
Specifically, individual chronic diseases are forecasted to increase significantly: dementia increases by 45%, diabetes increases by 49%, chronic pain increases by 32% – from 5.345 million people in 2019 to 7.247 million people in 2040, according to updates from The Guardian based on Health Foundation data. Multimorbidity (multiple pathologies, i.e., two or more chronic diseases at the same time) affects about 14.8% of the English population according to a 2020 whole-population study (more than 60 million people registered with GPs), with a higher rate in the deprived decile up to 25% or more, according to the ONS and related studies. This rate increases sharply with age: from less than 1% in the 0-19 age group to 68.2% in the over-80 group. Forecasts to 2049, another study on The Lancet Public Health shows that the multimorbidity rate could increase by 34%, from 53.8% to 71.9% of the population if there are no major changes in prevention.
These numbers are not just abstract statistics but reflect the daily life reality of millions of people. Take Mr. Tom, 52 years old in Manchester, as a typical example. Mr. Tom is one of about 3.6 million people over 70 years old who lived with major illness in 2019 (according to Health Foundation data), but he belongs to the middle-aged group facing metabolic syndrome – a metabolic syndrome including central obesity, hypertension, dyslipidemia, and insulin resistance – often leading to type 2 diabetes and cardiovascular disease. In 2022, he was diagnosed with pre-diabetes with a HOMA-IR (Homeostatic Model Assessment for Insulin Resistance) index at 4.2 (normal threshold below 2.5), along with an average blood pressure of 145/90 mmHg and high triglycerides of 2.8 mmol/L. As a truck driver, he works long shifts, eats irregularly (often fast food high in carbs and saturated fat), is less active and has high stress due to traffic pressure. These factors increase the risk of progressing to full diabetes, with the risk of cardiovascular complications doubling according to the Framingham Risk Score.
The impact on Mr. Tom is multidimensional: physically, prolonged fatigue, blurred vision in the morning (due to hyperglycemia), back pain due to being overweight; mentally, constant anxiety about the family’s future – his wife has to provide extra care, children worry about medical costs. “Statistics on the increase of chronic diseases made me realize I’m not alone, but also motivated me to act before it’s too late,” Mr. Tom shared in a community consultation session. He started to change by reducing refined carbs to below 130g/day according to NICE guidelines for prediabetes, increasing aerobic activity to 150 minutes/week, and monitoring blood sugar at home. Results after 18 months: HOMA-IR decreased to 2.9, blood pressure stabilized at 128/82 mmHg, lost 8kg, and he avoided a full diabetes diagnosis. However, he still needs continuous support to maintain, as aging population forecasts will increase the multimorbidity burden, especially in the middle-aged group like him with a modern lifestyle.
Another case is Ms. Aisha, 38 years old in Birmingham, belonging to the South Asian ethnic group – a group with twice the average risk of diabetes according to the British Heart Foundation. She was diagnosed with early multimorbidity: type 2 diabetes (HbA1c 7.8%), hypertension, and mild depression. The multimorbidity rate in the younger group (20-49 years old) is increasing, with depression and asthma being common, according to population-wide data. Ms. Aisha felt exhausted: sales work made her have little time to take care of herself, leading to early complications such as neuropathy (numbness in feet). “I’m afraid I won’t be able to take care of my children if the disease gets worse,” she shared with deep anxiety. Through monitoring, she reduced HbA1c to 6.5% thanks to metformin and lifestyle changes, but needs a multidisciplinary support team for long-term management.
These data emphasize the need for early action: preventing multimorbidity through screening (such as HbA1c, periodic blood pressure) and lifestyle interventions, because population aging will push the burden on the NHS if there are no proactive solutions.
High Costs and Social Burden of Chronic Disease on NHS UK – Detailed Analysis and Real Examples
Chronic disease accounts for the majority of the NHS budget, with estimates of direct costs for long-term conditions accounting for about 70% of total health spending according to analyses from King’s Fund and other sources. Total spending of the Department of Health and Social Care in 2024/25 reached about £204.7 billion, in which NHS England receives the majority for daily services. For diabetes alone, direct costs are estimated at £10.7 billion in 2021/22 (updated from York Health Economics Consortium 2024 study), with more than 40% for diagnosis and treatment, the rest for complications such as kidney failure, stroke, and amputations. Total indirect costs (loss of labor productivity) add £3.3 billion, and if trends continue, diabetes costs could reach £18 billion by 2035. Cardiovascular disease costs inpatient care about £6.732 billion according to Lancet data, while unhealthy food-related conditions (related to poor diet) are estimated at £268 billion overall.
The social burden is even greater: hospital admissions increase, waiting times for examinations extend, and loss of labor productivity affects families and communities. Mrs. Margaret, 72 years old in Edinburgh, is a typical example. She lives with rheumatoid arthritis and osteoporosis – two common diseases in elderly women after menopause due to decreased estrogen leading to increased inflammatory cytokines such as TNF-alpha. DAS28 (Disease Activity Score 28) of her is at 5.1 (medium-high disease activity), causing knee and hip joint pain making it difficult for her to take care of grandchildren. She is hospitalized twice/year due to flare-ups (inflammation outbreaks), each time costing about £4,000 for the NHS (including tests, biological drugs such as etanercept and rehabilitation), plus personal productivity loss estimated at £5,000/year (time off work to take care of herself and family). “It’s not just about money, it’s isolation from the community – I see friends less, I feel like a burden,” she shared with deep sadness.
Her process: initially using methotrexate reduced symptoms by 20%, but needed to coordinate DMARDs (disease-modifying antirheumatic drugs) and vitamin D/calcium supplementation according to NICE guidelines to reduce fracture risk by 50%. However, waiting for a DEXA scan (measuring bone density) took six months, leading to slow progress. Result: pain decreased by 40% after adjustment, but she still needs continuous support to maintain quality of life. Social impact: her children have to arrange time for care, affecting work, and the local community loses her participation in volunteer activities.
Similarly, costs for chronic pain – forecast to increase by 1.9 million cases by 2040 – increase the burden of painkillers and rehabilitation. These numbers show that chronic disease is not only a medical issue but also socio-economic, requiring proactive solutions to offload the NHS.
Better Control and Improved Quality of Life Thanks to Personal Care Team (PCT) and Multidisciplinary Team (MDT)
Multidisciplinary team (MDT) – provides clear benefits in chronic disease management, with a 20-30% reduction in complications and a 40% increase in patient satisfaction according to recent BMJ and Lancet studies. MDT improves clinical outcomes by coordinating indicator monitoring (such as blood pressure, HbA1c), adjusting lifestyle and psychological support, reducing fragmented care. For example, in diabetic patients, MDT helps reduce average HbA1c by 0.38%, systolic blood pressure by 5.88 mmHg and diastolic by 3.23 mmHg according to meta-analysis.
For Emily, 45 years old in London, living with chronic pain (back pain after injury) and mild depression, PCT (similar to MDT) has changed her life. Her VAS (Visual Analog Scale) pain went from 7/10 down to 3/10 after six months thanks to coordinating a physical therapist (guiding core strengthening exercises and ergonomics) and a psychologist (CBT – Cognitive Behavioral Therapy to change negative thoughts about pain). PHQ-9 (Patient Health Questionnaire-9 for depression) decreased from 12 down to 5, improving sleep and work ability. Emily feels “listened to and comprehensively supported”, reduced anxiety and increased compliance.
StrongBody AI enhances this benefit through instant matching: Emily builds a PCT with a physical therapist and a psychologist, receives CBT sessions offer (8-week plan, monitoring voice messages), leading to multifaceted results – better physical, positive spirit, reduced dependence on opioid painkillers (reducing addiction risk according to NICE).
StrongBody AI: Smart Matching – The Pioneering Solution for Chronic Disease Management UK
StrongBody AI is a global health & wellness marketplace platform with tens of millions of users from more than 50 countries, using Smart Matching AI to build a Personal Care Team instantly based on the buyer’s health interests. Integrated with MultiMe Chat (translation of 194 languages, voice translation) and secure escrow payment via Stripe/PayPal, the platform connects buyers with specialized sellers such as Nutrition Doctor, Psychologist, or Longevity Coach.
For Mr. Raj, 60 years old in Leicester, AI matching paired him with an endocrinologist (monitoring HOMA-IR) and a resilience coach (managing stress). Process: registration, selecting metabolic syndrome interest; system proposes PCT; he sends a private request about diet; receives a low-GI 1,800 calories/day plan offer; accepts £60 payment; monthly monitoring via chat with meal images and voice messages. Result after four months: HOMA-IR decreased from 4.2 down to 2.8, blood pressure stabilized, lost 6kg, and he feels more confident in disease management.
Optimizing Chronic Pain and Depression Management Thanks to StrongBody AI
Mrs. Sarah, 62 years old in London, suffering from knee joint pain (osteoarthritis) and depression for eight years, VAS 7/10, PHQ-9 12. Registering StrongBody AI, Smart Matching AI built PCT: German rheumatologist (monitoring DAS28), Australian PT (home exercises), Canadian CBT (relaxation techniques), Indian mindfulness. Private request about symptoms led to a six-month plan offer: combined NSAID drugs, thigh muscle strengthening exercises, weekly CBT via video call. She accepted, paid safely; monitored progress with image evidence and voice messages. Result: VAS decreased 60% down to 3/10, PHQ-9 from 12 down to 5, walking 5km/day, reduced drug dependence, positive spirit, and maintained long-term. StrongBody AI has integrated naturally, bringing proactive care beyond NHS limits.
Build Your Team Today with StrongBody AI
Register now at https://strongbody.ai to build a Personal Care Team instantly. Proactively manage chronic disease management UK with personalized solutions from StrongBody AI – start your journey to better health today!
Overview of StrongBody AI
StrongBody AI is a platform connecting services and products in the fields of health, proactive health care, and mental health, operating at the official and sole address: https://strongbody.ai. The platform connects real doctors, real pharmacists, and real proactive health care experts (sellers) with users (buyers) worldwide, allowing sellers to provide remote/on-site consultations, online training, sell related products, post blogs to build credibility, and proactively contact potential customers via Active Message. Buyers can send requests, place orders, receive offers, and build personal care teams. The platform automatically matches based on expertise, supports payments via Stripe/Paypal (over 200 countries). With tens of millions of users from the US, UK, EU, Canada, and others, the platform generates thousands of daily requests, helping sellers reach high-income customers and buyers easily find suitable real experts.
Operating Model and Capabilities
Not a scheduling platform
StrongBody AI is where sellers receive requests from buyers, proactively send offers, conduct direct transactions via chat, offer acceptance, and payment. This pioneering feature provides initiative and maximum convenience for both sides, suitable for real-world health care transactions – something no other platform offers.
Not a medical tool / AI
StrongBody AI is a human connection platform, enabling users to connect with real, verified healthcare professionals who hold valid qualifications and proven professional experience from countries around the world.
All consultations and information exchanges take place directly between users and real human experts, via B-Messenger chat or third-party communication tools such as Telegram, Zoom, or phone calls.
StrongBody AI only facilitates connections, payment processing, and comparison tools; it does not interfere in consultation content, professional judgment, medical decisions, or service delivery. All healthcare-related discussions and decisions are made exclusively between users and real licensed professionals.
User Base
StrongBody AI serves tens of millions of members from the US, UK, EU, Canada, Australia, Vietnam, Brazil, India, and many other countries (including extended networks such as Ghana and Kenya). Tens of thousands of new users register daily in buyer and seller roles, forming a global network of real service providers and real users.
Secure Payments
The platform integrates Stripe and PayPal, supporting more than 50 currencies. StrongBody AI does not store card information; all payment data is securely handled by Stripe or PayPal with OTP verification. Sellers can withdraw funds (except currency conversion fees) within 30 minutes to their real bank accounts. Platform fees are 20% for sellers and 10% for buyers (clearly displayed in service pricing).
Limitations of Liability
StrongBody AI acts solely as an intermediary connection platform and does not participate in or take responsibility for consultation content, service or product quality, medical decisions, or agreements made between buyers and sellers.
All consultations, guidance, and healthcare-related decisions are carried out exclusively between buyers and real human professionals. StrongBody AI is not a medical provider and does not guarantee treatment outcomes.
Benefits
For sellers:
Access high-income global customers (US, EU, etc.), increase income without marketing or technical expertise, build a personal brand, monetize spare time, and contribute professional value to global community health as real experts serving real users.
For buyers:
Access a wide selection of reputable real professionals at reasonable costs, avoid long waiting times, easily find suitable experts, benefit from secure payments, and overcome language barriers.
AI Disclaimer
The term “AI” in StrongBody AI refers to the use of artificial intelligence technologies for platform optimization purposes only, including user matching, service recommendations, content support, language translation, and workflow automation.
StrongBody AI does not use artificial intelligence to provide medical diagnosis, medical advice, treatment decisions, or clinical judgment.
Artificial intelligence on the platform does not replace licensed healthcare professionals and does not participate in medical decision-making.
All healthcare-related consultations and decisions are made solely by real human professionals and users.
Step 1: Register a Seller account for health and wellness experts:
- Access the website https://strongbody.ai or any link belonging to StrongBody AI.
- Click Sign Up (top right corner of the screen).
- Choose to register a Seller account.
- Enter your email and password to create an account.
- Complete the registration and log in to the system.
Immediately after registration, the system will guide you step-by-step to complete your profile and open your store.
STEP 2: Complete Seller Information (5 Minutes)
A standard Seller account requires full information to begin receiving transactions from customers.
Mandatory Personal Information:
– Full name, gender, and geographical address.
– Profession/Expertise relevant to the StrongBody AI fields.
Profile Imagery:
– Avatar: Real photo, clear face, matching gender and nationality.
– Profile Cover: Real photo showing your workspace, including people.
Real photos significantly increase trust and booking rates.
Introduction & Qualifications:
– Self-description matching your expertise, reflecting professional spirit.
– Educational background, degrees, and certifications.
– Practical Experience: Minimum of 1 year, clearly describing past roles.
– At least 2 relevant professional skills.
– At least 1 professional practice certificate/license.
Payment Information:
– Complete the Seller’s credit card information.
STEP 3: Post Services – MANDATORY for Doctors & Experts
Minimum Requirements:
– At least 02 Online services.
– At least 01 Offline or Hybrid service.
A High-Quality Service Needs:
– Alignment with the Seller’s expertise.
– Clear Description of:
+ Scope of work.
+ Service duration/delivery time.
+ Benefits for the customer.
+ Personal competence and commitment.
– At least 5 illustrative images.
– Language: Seller’s native language or English.
Support from StrongBody AI:
– Seller Assistant (AI Tool):
+ Suggests services matching your expertise.
+ Guides structure and presentation.
+ Increases professionalism and conversion rates.
STEP 4: Post Products – MANDATORY for Pharmacists & Health Product Sellers
(Products are for sharing and direct sale, not via a shopping cart)
Minimum Requirements:
– At least 2 products relevant to your expertise.
– Recommendation: 3–5+ products to increase conversion.
Required Product Information:
– Full product name, origin, and manufacturer.
– Key functions or standout advantages.
– Reference price.
– At least 2 illustrative images.
– Content in the Seller’s national language.Note: StrongBody AI does not process product payments. Buyers will contact the Seller directly for transactions and shipping.
STEP 5: Write Blogs (OPTIONAL – Highly Recommended)
Blogs help increase credibility and conversion rates (by ~30%).
Suggestions:
– At least 2 blog posts.
– Topics: Expertise, professional perspectives, career journey, public health.
– Each post should have:
+ Illustrative photos.
+ Relevant keywords.
+ In-depth content with evidence/data.
+ While not mandatory, blogs help Sellers gain more trust and selections.
STEP 6: Immediate Store Visibility
– As soon as you have:
+ An Avatar
+ Listed Expertise
+ Highlighted Skills
Your shop profile will be public immediately.
– Customers can then:
+ Access your profile.
+ Send messages.
+ Submit service requests.
Meanwhile, Sellers can continue adding services, products, and blogs to perfect the store.
Standout Advantages of StrongBody AI
– No tech knowledge required: Open your store in minutes.
– Global reach: Connect with customers worldwide.
– All-in-one: Combine services, products, and professional content on a single profile.
